amlodipine/valsartan/hydrochlorothiazide
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 27, 2022
DINAMICS OF ARTERIAL STIFFNESS USING CAVI INDEX DEPENDS ON ADDED STATIN TO FIXED COMBINATION ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION.
(PubMed, J Hypertens)
- "The added of statin to fixed combination antihypertensive therapy prevented the progression of arterial stiffness in patients with arterial hypertension."
Journal • Cardiovascular • Diabetes • Hypertension • Metabolic Disorders • Pulmonary Arterial Hypertension
July 30, 2020
[VIRTUAL] Single pill regimen improves persistence and leads lo better clinical outcome compared to identical multi pill combination. Results of START, a German claims data analysis
(ESC 2020)
- "Each group included 10,801 patients with valsartan/amlodipine, 1,026 with candesartan/amlodipine, 1,823 with amlodipine/valsartan/hydrochlorothiazide (HCT), and 15,349 with ramipril/amlodipine as SP or identical LC. Conclusion A SP regimen improves persistence to medication, reduces cardiovascular events and total mortality compared to identical LC. The results of the START study strongly support the use of a SP concept in the AH medication treatment as recommended by the current ESH/ESC-Guidelines for the treatment of AH."
Clinical • Clinical data • Cardiovascular • Congestive Heart Failure • Coronary Artery Disease • Heart Failure • Hypertension • Myocardial Infarction
January 21, 2020
Efficacy and safety of amlodipine/valsartan/hydrochlorothiazide single pill combination in Egyptian patients with hypertension uncontrolled on any dual therapy: an observational study.
(PubMed, Curr Med Res Opin)
- "Aml/Val/HCT SPC significantly reduced BP and was well tolerated in Egyptian patients with hypertension not controlled on any previous dual therapy."
Clinical • Journal • Observational data
1 to 3
Of
3
Go to page
1